
Glidum MF 0.5mg/500mg Tablet SR
Marketer
Knoll Pharmaceuticals Ltd
Salt Composition
Glimepiride (0.5mg) + Metformin (500mg)
Overview Glidum MF 0.5mg/500mg Tablet SR
Diabexe Duo 0.5mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption increases hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.
Primary Ingredients of Glidum MF 0.5mg/500mg Tablet SR
There is no text provided to rephrase.
Uses of Glidum MF 0.5mg/500mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Glidum MF 0.5mg/500mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or dividing it. Consume the Glidum MF 0.5mg/500mg sustained-release tablet with food.
Common Side effects of Glidum MF 0.5mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glidum MF 0.5mg/500mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume the Glidum MF 0.5mg/500mg sustained-release tablet with food.
How Glidum MF 0.5mg/500mg Tablet SR works:
Glidum MF 0.5mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glidum MF 0.5mg/500mg Tablet SR with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glidum MF 0.5mg/500mg sustained-release tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice before taking this medication.
Breast feedingUNSAFE
Prolonged-release Glidum MF 0.5mg/500mg tablets are contraindicated during lactation. Evidence indicates a potential for infant harm due to the medication.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Glidum MF 0.5mg/500mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glidum MF 0.5mg/500mg Tablet SR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glidum MF 0.5mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is recommended. In those with mild to moderate hepatic dysfunction, initiation should be at a low dose; the medication is contraindicated in patients with severe liver disease.
What if you forget to take Glidum MF 0.5mg/500mg Tablet SR :
Should you forget a Glidum MF 0.5mg/500mg SR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glidum MF 0.5mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes medication |
